This inventor holds 0 USPTO granted patents, plus 14 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Dong Liu - Innovator in Pharmaceutical Chemistry
Introduction
Dong Liu is a notable inventor based in China, recognized for his contributions to pharmaceutical chemistry. He has developed innovative methods and compounds that hold promise in the medical field. His work primarily focuses on the synthesis of nitrogen-containing heterocyclic compounds and their applications in treating various diseases.
Latest Patents
Dong Liu has recently filed patents for two significant inventions. The first patent is for a benzofuran derivative, which includes a preparation method and its use in medicine. This invention specifically addresses the use of the benzofuran derivative as an EZH2 inhibitor, which is crucial in the prevention and treatment of tumors and cancers, including non-Hodgkin's lymphoma and diffuse large B-cell lymphoma. The second patent involves a method for preparing nitrogen-containing heterocyclic compounds through an enzymatic-chemical cascade method. This innovative approach utilizes alcohol dehydrogenase as a catalyst, offering a greener and more economical alternative to traditional methods.
Career Highlights
Throughout his career, Dong Liu has worked with prominent companies such as Yantai Jereh Oilfield Services Group Co., Ltd. and Yantai Jereh Petroleum Equipment & Technologies Co., Ltd. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.
Collaborations
Dong Liu has collaborated with several professionals in his field, including Dongdong Chen and Biao Deng. These partnerships have facilitated the exchange of ideas and advancements in their respective areas of research.
Conclusion
Dong Liu's innovative work in pharmaceutical chemistry, particularly in the development of new compounds and methods, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile